Immunai is a biotechnology company focused on mapping the immune system with unparalleled scale and precision to advance the field of immunomodulatory therapeutics. The company offers a platform that combines multi-omic single-cell analysis with machine learning and functional genomics to drive therapeutic discovery and accelerate drug development. Immunai partners with biopharmaceutical companies and academic research institutions to leverage patient-derived multi-omic data for target and therapeutic discovery.